Impact of adding raltegravir to antiretroviral regimens in patients with blood viral suppression but persistent seminal viral shedding
Virological and immunological responses to raltegravir and dolutegravir in the gut-associated lymphoid tissue of HIV-infected men and women.
Tags: AIDS, antiretroviral, HIV, integrase inhibitor, Isentress®
BASi Method Number SAP.761
Sign up and you’ll receive the latest updates that matter to you, delivered straight to your inbox.